GRP
AMLX icon

Global Retirement Partners’s Amylyx Pharmaceuticals AMLX Stock Holding History

Global Retirement Partners’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,000
Closed -$13.6K – 4237
2025
Q3 		$13.6K Sell
1,000
-1,500
-60% -$14.1K ﹤0.01% 2565
2025
Q2 		$16K Buy
+2,500
New +$12.2K ﹤0.01% 2392
2024
Q4 		$1.51K Buy
+400
New +$1.88K ﹤0.01% 3171
2024
Q1 		– Sell
-200
Closed -$3.1K – 3388
2023
Q4 		$3.1K Buy
+200
New +$3.06K ﹤0.01% 2509

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Global Retirement Partners's AMLX Position: Q4 2025 in Review

Global Retirement Partners sold out of Amylyx Pharmaceuticals (AMLX) in Q4 2025, closing a stake of 1,000 shares — an estimated $13.6K sold.

Global Retirement Partners first reported a position in AMLX in Q4 2023 and held it in 4 quarters. The position peaked at $16K in Q2 2025. 179 funds tracked by Wall St. Rank hold AMLX as of Q4 2025.

  • Global Retirement Partners reported no remaining Amylyx Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Global Retirement Partners sold 1,000 Amylyx Pharmaceuticals shares in Q4 2025, an estimated $13.6K.
  • Global Retirement Partners first reported a position in Amylyx Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Global Retirement Partners's Amylyx Pharmaceuticals position peaked at $16K in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.